INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE
Beyond the five-year horizon: long-term outcome of high-risk and inoperable patients undergoing TAVR with first-generation devices
EuroIntervention 2018;14:41-49 published online March 2018. DOI: 10.4244/EIJ-D-17-00603
Marcus-André Deutsch1,2,3*, MD; Magdalena Erlebach1,2, MD; Melchior Burri1,2, MD; Alexander Hapfelmeier4, PhD; Olivia Ganga Witt1; Johannes Amadeus Ziegelmueller1,2, MD; Michael Wottke1, MD; Hendrik Ruge1,2, MD; Markus Krane1,2,3, MD; Nicolo Piazza1,5, MD, PhD; Sabine Bleiziffer1,2, MD; Rüdiger Lange1,2,3, MD, PhD
1. Department of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München, Munich, Germany; 2. Insure (Institute for Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Center Munich at the Technica
Aims: We sought to determine the long-term outcome of high-risk patients who underwent transcatheter aortic valve replacement (TAVR) with first-generation devices with a focus on the iden